Isomorphic Labs & Alphabet Inc. — Google DeepMind

Isomorphic Labs: Isomorphic Labs, the AI drug discovery company, remains under Hassabis's leadership. He will spend more time there, potentially accelerating its work in biomedical applications.

Alphabet Inc. — Google DeepMind: Alphabet Inc. — Google DeepMind is the AI lab at the center of the reshuffle. Hassabis steps back as CEO, Kavukcuoglu takes over daily leadership, and several senior researchers depart, potentially affecting research momentum.

Isomorphic Labs: Isomorphic Labs, Alphabet's drug discovery spinout, gains some former AlphaFold researchers, potentially benefiting from their expertise.

Alphabet Inc. — Google DeepMind: Alphabet Inc. — Google DeepMind is the entity executing the restructuring, shifting focus from specialized teams to Gemini-powered general AI, which may impact its scientific research output.

Isomorphic Labs: Some members of John Jumper's protein-folding research team have moved to Isomorphic Labs, an Alphabet spinout, indicating internal talent shifts within Alphabet's AI ecosystem.

Alphabet Inc. — Google DeepMind: Alphabet Inc. — Google DeepMind is losing several key researchers, including Nobel laureate John Jumper, Jonas Adler, and Alexander Wang, to competitors like Anthropic, which could hinder its AI development efforts.